Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases

International Journal of Molecular Sciences
Eddy OwagaJung-Su Chang

Abstract

Inflammatory bowel diseases (IBD) are characterized by wasting and chronic intestinal inflammation triggered by various cytokine-mediated pathways. In recent years, it was shown that T helper 17 (Th17) cells are involved in the pathogenesis of IBD, which makes them an attractive therapeutic target. Th17 cells preferentially produce interleukin (IL)-17A-F as signature cytokines. The role of the interplay between host genetics and intestinal microbiota in the pathogenesis of IBD was demonstrated. Probiotics are live microorganisms that when orally ingested in adequate amounts, confer a health benefit to the host by modulating the enteric flora or by stimulating the local immune system. Several studies indicated the effectiveness of probiotics in preventing and treating IBD (ulcerative colitis, and Crohn's disease). Furthermore, there is mounting evidence of probiotics selectively targeting the Th17 lineage in the prevention and management of inflammatory and autoimmune diseases such as IBD. This review highlights critical roles of Th17 cells in the pathogenesis of IBD and the rationale for using probiotics as a novel therapeutic approach for IBD through manipulation of Th17 cells. The potential molecular mechanisms by which probi...Continue Reading

References

Mar 25, 2000·Journal of Leukocyte Biology·R Boismenu, Y Chen
Jun 2, 2000·Gastroenterology·T KinugasaH C Reinecker
Aug 29, 2000·Digestive Diseases and Sciences·M GuslandiP A Testoni
Oct 25, 2000·Journal of Pediatric Gastroenterology and Nutrition·P GuptaS Guandalini
Dec 1, 2000·Scandinavian Journal of Gastroenterology·A VenkatramanS Murthy
Sep 7, 2002·The British Journal of Nutrition·Fergus Shanahan
Feb 6, 2003·Journal of the American College of Nutrition·Hideki IshikawaToru Otani
Mar 8, 2003·Alimentary Pharmacology & Therapeutics·J KuismaM Farkkila
Apr 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masahide MiyamotoAnders Lindén
Feb 14, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Atsuhiro OgawaYoshihide Fujiyama
Apr 27, 2004·Diseases of the Colon and Rectum·Martijn P GosselinkJohanneke G H Ruseler-van Embden
Apr 29, 2004·BMC Gastroenterology·Michael SchultzHeiko C Rath
Jun 30, 2005·The American Journal of Gastroenterology·Rodrigo BibiloniR Balfour Sartor
Oct 4, 2005·Alimentary Pharmacology & Therapeutics·B ShenB A Lashner
May 4, 2006·Inflammatory Bowel Diseases·Zili ZhangJay K Kolls
May 4, 2006·The Journal of Clinical Investigation·Yoichiro Iwakura, Harumichi Ishigame
May 16, 2006·Alimentary Pharmacology & Therapeutics·M A ZoccoA Gasbarrini
Jul 5, 2006·Nature Clinical Practice. Gastroenterology & Hepatology·R Balfour Sartor
Sep 30, 2006·World Journal of Gastroenterology : WJG·Julia B Ewaschuk, Levinus A Dieleman
Feb 6, 2007·The Journal of Biological Chemistry·Xuexian O YangChen Dong
Feb 20, 2007·Inflammatory Bowel Diseases·Marla C DubinskyUNKNOWN Western Regional Research Alliance for Pediatric IBD
Feb 22, 2007·The Journal of Nutrition·Barbara SheilLiam O'Mahony
Mar 10, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·Iris DotanLloyd Mayer
May 4, 2007·Inflammatory Bowel Diseases·Nathalie Rolhion, Arlette Darfeuille-Michaud
Jul 20, 2007·The Proceedings of the Nutrition Society·Charlotte HedinJames O Lindsay
Sep 28, 2007·International Journal of Medical Microbiology : IJMM·Hiromasa TakaishiToshifumi Hibi
Feb 19, 2008·British Journal of Clinical Pharmacology·Dimitrios Damaskos, George Kolios
Apr 4, 2008·Molecular Nutrition & Food Research·Philippe SeksikPhilippe Marteau
Apr 16, 2008·The Journal of Experimental Medicine·Xuexian O YangChen Dong
Jun 6, 2008·Alimentary Pharmacology & Therapeutics·R Spiller
Sep 18, 2008·Biochemical and Biophysical Research Communications·Reiko ItoOsam Mazda

❮ Previous
Next ❯

Citations

Apr 10, 2017·Digestive Diseases and Sciences·Bo CaoLiu Hong
Sep 5, 2019·Infection and Immunity·Marjolaine Vareille-DelarbreChristiane Forestier
Jul 12, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Chunyan WangLi Zhang
May 10, 2020·ACR Open Rheumatology·Madison GrinnellKaleb Michaud
Aug 31, 2018·Frontiers in Immunology·Veronica LazarMariana Carmen Chifiriuc
Oct 23, 2018·World Journal of Gastroenterology : WJG·Natalia Schneider NunesJoseph Alan Frank
Jan 11, 2020·Frontiers in Microbiology·Xianping LiZhihong Ren
Jan 24, 2019·World Journal of Gastroenterology : WJG·Carolina Vieira De AlmeidaAmedeo Amedei
Aug 12, 2018·Nutrients·Lourdes Santiago-LópezAarón F González-Córdova
Aug 6, 2016·Pathogens and Disease·Joseph KuoRonald F Schell
May 13, 2017·Frontiers in Immunology·Nicola L DinyDaniela Čiháková
Oct 28, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Roghayeh ShahbaziChantal Matar
Jun 7, 2018·Cell Metabolism·Francesca CignarellaLaura Piccio
May 23, 2020·ACG Case Reports Journal·Amir NazarianDon Thiwanka Wijeratne
May 6, 2021·Animals : an Open Access Journal From MDPI·Xiaoyuan WeiJiangchao Zhao
Oct 17, 2021·Expert Review of Gastroenterology & Hepatology·Shaghayegh Baradaran GhavamiMassoud Vosough
Nov 30, 2018·Case Reports in Gastroenterology·Jobin PhiliposeVivek V Gumaste

❮ Previous
Next ❯

Methods Mentioned

BETA
IECs
IEC
nuclear translocation

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Related Papers

Critical Reviews in Food Science and Nutrition
Larissa Sbaglia CelibertoDaniela Cardoso Umbelino Cavallini
Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition
Sophie Drouault-HolowaczBruno Pot
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association
Ebtissam S Almeghaiseeb
© 2021 Meta ULC. All rights reserved